SEARCH

SEARCH BY CITATION

References

  • Arroyo S, Dodson WE, Privitera MD, Glauser TA, Naritoku DK, Dlugos DJ, Wang S, Schwabe SK, Twyman RE. (2005) Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 112:214222.
  • Baulac M, Brodie MJ, Patten A, Segieth J, Giorgi L. (2012) Comparison of the efficacy and tolerability of zonisamide and controlled release carbamazepine in newly diagnosed partial epilepsy: a phase 3, randomized, double-blind, non-inferiority trial. Lancet Neurol 11:579588.
  • Bill PA, Vigonius U, Pohlmann H, Guerreiro CA, Kochen S, Saffer D, Moore A. (1997) A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res 27:195204.
  • Bourgeois B, Brown L, Pellock J, Buroker M, Greiner M, Garofalo E, Schimschock J, Griesemer D, Bebin M, Murphy J. (1998) Gabapentin(Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes(BECTS): a 36-week, double-blind, placebo-controlled study. Epilepsia 39:163.
  • Brodie MJ, Richens A, Yuen AW. (1995) Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345:476479. [published erratum appears in Lancet 1995 Mar 11;345(8950):662] [see comments].
  • Brodie MJ, Overstall PW, Giorgi L. (1999) Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 37:8187.
  • Brodie MJ, Chadwick DW, Anhut H, Otte A, Messmer SL, Maton S, Sauermann W, Murray G, Garofalo EA. (2002a) Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 43:9931000.
  • Brodie MJ, Wroe SJ, Dean AD, Holdich TA, Whitehead J, Stevens JW. (2002b) Efficacy and safety of remacemide versus carbamazepine in newly diagnosed epilepsy: comparison by sequential analysis. Epilepsy Behav 3:140146.
  • Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ. (2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68:402408.
  • Callaghan N, Ohara J, Odriscoll D, Oneill B, Daly M. (1982) Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petitmal). Dev Med Child Neurol 24:830836.
  • Callaghan N, Kenny R, O'Neilll B, Crowley M, Goggin T. (1985) A prospective study between carbamazepine, phenytoin, and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry 48:639644.
  • Canadian Study Group for Childhood Epilepsy. (1998) Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. Epilepsia 39:952959.
  • Chadwick D. (1999) Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet 354:1319.
  • Chadwick DW, Anhut H, Greiner MJ, Alexander J, Murray GH, Garofalo EA, Pierce MW. (1998) A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 51:12821288.
  • Christe W, Kramer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, Moore A. (1997) A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 26:451460.
  • Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. (2004) Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia 45:10491053.
  • Coppola G, Franzoni E, Verrotti A, Garone C, Sarajlija J, Operto FF, Pascotto A. (2007) Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. Brain Dev 29:281284.
  • Dam M, Ekberg R, Loyning Y, Waltimo O, Jakobsen K. (1989) A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. J Neurol Neurosurg Psychiatry 52:472476.
  • de Silva M, MacArdle B, McGowan M, Hughes E, Stewart J, Neville BG, Johnson AL, Reynolds EH. (1996) Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 347:709713.
  • Eun S-H, Kim HD, Eun B-L, Lee IK, Chung HJ, Kim JS, Kang H-C, Lee Y-M, Suh ES, Kim DW, Eom S, Lee JS, Moon HK. (2011) Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. Seizure 20:558563.
  • Fattore C, Boniver C, Capovilla G, Cerminara C, Citterio A, Coppola G, Costa P, Darra F, Vecchi M, Perucca E. (2011) A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. Epilepsia 52:802809.
  • Feksi AT, Kaamugisha J, Sander JW, Gatiti S, Shorvon SD. (1991) Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group). Lancet 337:406409.
  • Frank LM, Enlow T, Holmes GL, Manasco P, Concannon S, Chen C, Womble G, Casale EJ. (1999) Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 40:973979.
  • Gamble C, Williamson PR, Chadwick DW, Marson AG. (2006a) A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Neurology 66:13101317.
  • Gamble CL, Williamson PR, Marson AG. (2006b) Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database Syst Rev CD001031.
  • Genton P. (2000) When antiepileptic drugs aggravate epilepsy. Brain Dev 22:7580.
  • Gibberd FB, Park DM, Scott G, Gawel MJ, Fry DE, Page NG, Engler C, English JR, Rose FC. (1982) A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial. J Neurol Neurosurg Psychiatry 45:11131118.
  • Gilliam FG, Veloso F, Bomhof MA, Gazda SK, Biton V, Ter Bruggen JP, Neto W, Bailey C, Pledger G, Wu SC. (2003) A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 60:196202.
  • Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T. (2006) ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47:10941120.
  • Glauser TA, Dlugos DJ, Dodson WE, Grinspan A, Wang S, Wu SC. (2007) Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents. J Child Neurol 22:693699.
  • Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Capparelli EV, Adamson PC; Childhood Absence Epilepsy Study Group. (2010) Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 362:790799.
  • Guerreiro MM, Vigonius U, Pohlmann H, de Manreza ML, Fejerman N, Antoniuk SA, Moore A. (1997) A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 27:205213.
  • Guerrini R, Belmonte A, Genton P. (1998) Antiepileptic drug-induced worsening of seizures in children. Epilepsia 39:S2S10.
  • Heller AJ, Chesterman P, Elwes RDC, Crawford P, Johnson AL, Reynolds EH. (1995) Phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry 58:4450.
  • Kälviäinen R, Aikia M, Saukkonen AM, Mervaala E, Riekkinen PJ Sr. (1995) Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study. Arch Neurol 52:989996.
  • Koch MW, Polman SK. (2009) Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures. Cochrane Database Syst Rev CD006453.
  • Kwan P, Brodie MJ, Kälviänen R, Yurkewicz L, Weaver J, Knapp LE. (2011) Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial. Lancet Neurol 10:881890.
  • Levisohn PM, Holland KD. (2007) Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison. Epilepsy Behav 10:547552.
  • Loiseau P, Cohadon S, Jogeix M, Legroux M, Dartigues JF. (1984) [Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine]. Rev Neurol (Paris) 140:434437.
  • Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR. (2007a) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369:10001015.
  • Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR. (2007b) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369:10161026.
  • Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR. (2007c) A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess 11:iiiiv, ix–x, 1–134.
  • Martinovic Z. (1983) Comparison of ethosuximide with sodium valproate. In Parsonage M, Grant R, Craig AW Jr. (Eds) Advances in epileptology, XIVth epilepsy international symposium. Raven Press, New York, pp. 301305.
  • Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB, Homan RW, Crill WE, Lubozynski MF, Rosenthal NP, Mayersdorf A. (1985) Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 313:145151.
  • Mattson RH, Cramer JA, Collins JF. (1992) A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. [see comments] N Engl J Med 327:765771.
  • Mikkelsen B, Berggreen P, Joensen P, Kristensen O, Kohler O, Mikkelsen BO. (1981) Clonazepam (Rivotril) and carbamazepine (Tegretol) in psychomotor epilepsy: a randomized multicenter trial. Epilepsia 22:415420.
  • Muller M, Marson AG, Williamson PR. (2006) Oxcarbazepine versus phenytoin monotherapy for epilepsy. Cochrane Database Syst Rev CD003615.
  • Nieto-Barrera M, Brozmanova M, Capovilla G, Christe W, Pedersen B, Kane K, O'Neill F. (2001) A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res 46:145155.
  • Pal DK, Das T, Chaudhury G, Johnson AL, Neville BG. (1998) Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet 351:1923.
  • Pharmaceutical N. (2004) Trileptal Prescribing Information.
  • Placencia M, Sander JW, Shorvon SD, Roman M, Alarcon F, Bimos C, Cascante S. (1993) Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Res 14:237244.
  • Posner E. Absence seizures in children. Clin Evid (Online) Jan 10 doi:pii:0317.
  • Posner EB, Mohamed K, Marson AG. (2003) Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev CD003032.
  • Posner EB, Mohamed K, Marson AG. (2005) Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev CD003032.
  • Privitera MD, Brodie MJ, Mattson RH, Chadwick DW, Neto W, Wang S. (2003) Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 107:165175.
  • Ramsay RE, Wilder BJ, Berger JR, Bruni J. (1983) A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. Neurology 33:904910.
  • Ramsay RE, Wilder BJ, Murphy JV, Holmes GL, Uthman BM, Slater J, Morris DD, Shu V, Pierce MW. (1992) Efficacy and safety of valproic acid versus phenytoin as sole therapy for newly diagnosed primary generalized tonic-clonic seizures. J Epilepsy 5:5560.
  • Ramsay E, Faught E, Krumholz A, Naritoku D, Privitera M, Schwarzman L, Mao L, Wiegand F, Hulihan J; for the CAPSS-272 Study Group. (2010) Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial. Epilepsia 51:19701977.
  • Rastogi P, Mehrotra TN, Agarwala RK, Singh VS. (1991) Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy. J Assoc Physicians India 39:606608.
  • Rating D, Wolf C, Bast T. (2000) Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo- controlled study. Sulthiame Study Group. Epilepsia 41:12841288.
  • Reunanen M, Dam M, Yuen AW. (1996) A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res 23:149155.
  • Richens A, Davidson DL, Cartlidge NE, Easter DJ. (1994) A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. J Neurol Neurosurg Psychiatry 57:682687.
  • Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, Spitz M, Frederick T, Towne A, Carter GS, Marks W, Felicetta J, Tomyanovich ML. (2005) New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64:18681873.
  • Saetre E, Perucca E, Isojarvi J, Gjerstad L. (2007) An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 48:12921302.
  • Sato S, White BG, Penry JK, Dreifuss FE, Sackellares JC, Kupferberg HJ. (1982) Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 32:157163.
  • Shakir RA, Johnson RH, Lambie DG, Melville ID, Nanda RN. (1981) Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy. Epilepsia 22:2733.
  • Sobaniec W, Kulak W, Strzelecka J, Smigielska-Kuzia J, Bockowski L. (2005) A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children. Pharmacol Rep 57:646653.
  • Somerville ER. (2009) Some treatments cause seizure aggravation in idiopathic epilepsies (especially absence epilepsy). Epilepsia 50(Suppl. 8):3136.
  • Sommerfeld-Ziskin E, Ziskin E. (1940) The effect of phenobarbital on the mentality of epileptic patients. Arch Neurol Psychiatry 43:7079.
  • Steiner TJ, Dellaportas CI, Findley LJ, Gross M, Gibberd FB, Perkin GD, Park DM, Abbott R. (1999) Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 40:601607.
  • Steinhoff BJ, Ueberall MA, Siemes H, Kurlemann G, Schmitz B, Bergmann L. (2005) The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. Seizure 14:597605.
  • Tanganelli P, Regesta G. (1996) Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study. Epilepsy Res 25:257262.
  • Thilothammal N, Banu K, Ratnam RS. (1996) Comparison of phenobarbitone, phenytoin with sodium valproate: randomized, double-blind study. Indian Pediatr 33:549555.
  • Trudeau V, Myers S, LaMoreaux L, Anhut H, Garofalo E, Ebersole J. (1996) Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 11:470475.
  • Turnbull DM, Rawlins MD, Weightman D, Chadwick DW. (1982) A comparison of phenytoin and valproate in previously untreated adult epileptic patients. J Neurol Neurosurg Psychiatry 45:5559.
  • Turnbull DM, Howel D, Rawlins MD, Chadwick DW. (1985) Which drug for the adult epileptic patient: phenytoin or valproate? Br Med J (Clin Res Ed) 290:815819.
  • Verity CM, Hosking G, Easter DJ. (1995) A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group. Dev Med Child Neurol 37:97108.
  • Wheless JW, Neto W, Wang S. (2004) Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. J Child Neurol 19:135141.
  • Zamponi N, Cardinali C. (1999) Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children. Arch Neurol 56:605607.